Abstract:Neuropsychiatric and physical illnesses are frequently co-morbid. Many of these mental and physical health outcomes can be traced back to the fetal period, a critical period of development that lays the groundwork for brain and organ system architecture. Fetal programming is a key concept within the broader developmental origins of health and disease framework, which recognizes the importance of the prenatal and early postnatal environment to health throughout life. The fetus adapts to environmental exposures, and altered biological systems can have long- term effects on child and adult health (Barker, 2007). Individual variations in exposure to psychological stress and dysregulated metabolism in the prenatal period may impact fetal development, with long-term effects on the child's neurocognitive and physical health (Bale, 2010; Godfrey & Barker, 2001; Massin, 2001; Tamashiro & Moran, 2010). The fetus is sensitive to important in-utero exposures, such as maternal nutritional, psychological, and endocrine signals (Cottrell & Seckl, 2009). These signals are believed to convey information about the surrounding environment to the fetus in order to prepare it for life after birth and to allow for changes in the programming of growing systems (Howland, 2017). The fetal and early neonatal period is critical for understanding the application of psychoneuroendocrinology from basic science to better health. Research examining the fetal origins of health and disease has long studied the individual impacts of psychoneuroendocrinology and metabolism early in life. A growing body of research seeks to integrate the study of psychoneuroendocrinology, stress, and metabolism together into our fundamental understanding of early growth and the developing brain. The studies presented in this multidisciplinary symposium span novel biomarker discovery, prenatal maternal metabolic functioning and infant neuroimaging, and a clinical trial of a maternal mental health intervention and offspring growth. This symposium integrates psychoneuroendocrinology, metabolism, and neurodevelopment to better understand shared stress-metabolism mechanisms underlying neurodevelopment alongside the potential for interventions to improve health outcomes. Dr. Claudia Buss will present some of the first observational evidence in humans that maternal obesity and nutritional status before and during pregnancy are associated with micro/macrostructural variation in the offspring hypothalamus. Maternal prepregnancy BMI is a surrogate measure of overnutrition linked to significant alterations in maternal-fetal metabolic, inflammatory, and endocrine biology. The hypothalamus is important in regulating energy balance through input from the periphery, circulating satiety hormones, and nutrients to regulate adult feeding decisions. Less is known about how prenatal and pre-pregnancy maternal nutritional status is associated with structural variation in the human newborn hypothalamus. These data highlight the importance of understanding the role of the hypothalamus in energy balance and obesity risk and how maternal factors can influence offspring health outcomes. In addition to maternal overnutrition during pregnancy, around 10% of pregnancies in the US are affected by gestational diabetes mellitus, which has been linked to neurodevelopmental consequences in children. However, there are few studies examining early-life neural markers in infants exposed to gestational diabetes mellitus. Dr. Lauren Shuffrey will present research that shows that maternal gestational diabetes mellitus is associated with EEG power differentially depending on infant birth weight. In infants exposed to gestational diabetes mellitus, increased birth weight was associated with increased relative theta EEG power and decreased relative beta and gamma EEG power. In contrast, increased birth weight in infants unexposed to gestational diabetes mellitus was linked to lower relative theta EEG power and higher relative beta and gamma EEG power. This research suggests that even in healthy mother-infant dyads, changes in fetal body composition may be one mechanism by which gestational diabetes mellitus is linked to poor neurodevelopmental outcomes. This study highlights the importance of understanding the impact of gestational diabetes mellitus on infant neurodevelopment and how alterations in fetal body composition may contribute to adverse outcomes. Dr. Phu Tran will also present novel biomarkers of fetal programming in the maternal gestational diabetes milieu with links to early iron deficiency. Gestational diabetes is a risk factor for congenital iron deficiency and reduced brain iron concentrations, which leads to persistent deficits in learning and memory, emotional regulation, social behavior, overall neurophysiologic development, and an increased risk of developing neuropsychiatric disorders even after iron supplementation. Dr. Tran will present a proof-of-concept study on novel biomarkers to measure changes in the developing brain physiology with distal, blood-derived exposomes. Exosomes are small, cell-derived vesicles that may provide novel means to monitor altered physiological development in the developing central nervous system. Exosomes are also readily available in peripheral circulation and can open a window into alterations in the developing brain that are otherwise challenging to access. This study focuses on how maternal metabolism in pregnancy (maternal gestational diabetes) is associated with cord blood-derived exosomal CNTN2 and BDNF levels in neonates at risk for poorer neurodevelopment due to congenital iron deficiency, highlighting another important pathway between maternal metabolic functioning in pregnancy and offspring neurodevelopment. Finally, Dr. Jenalee Doom's study is an experimental test of whether reducing prenatal depression improves birth outcomes and offspring cardiovascular health. Dr. Doom presents results from a randomized controlled trial of brief interpersonal psychotherapy vs. enhanced usual care in 240 pregnant individuals who screened high for depression and examines the RCT’s impact on metabolic risk factors for later cardiometabolic health: low birthweight, rapid postnatal weight gain, and breastfeeding cessation. This study highlights the importance of addressing maternal mental health during pregnancy and the potential impact on offspring health outcomes. In conclusion, the studies presented at this symposium highlight the importance of understanding the developmental origins of health and disease, as well as the need to investigate prenatal psychological and endocrinological factors in offspring health outcomes. Chaired by Dr. Brie Reid, with expertise in the developmental psychoneuroendocrinology of stress and nutrition interactions, this symposium also brings together researchers with expertise in psychobiology, metabolism, and neuroimaging, ranging from postdoctoral to assistant professor to full professor career stages. Ultimately, this symposium aims to engage the audience with questions on the interplay between metabolic, nutritional, and psychosocial adversity that may open up new research avenues into the mechanisms underlying fetal programming and the potential for interventions to improve offspring health outcomes.

Intergenerational transmission of obesity risk by fetal programming of hypothalamus development

Maternal pre-pregnancy BMI, offspring epigenome-wide DNA methylation, and childhood obesity: findings from the Boston Birth Cohort

Pre-pregnancy BMI Association with Maternal Phenotype and Offspring Neurobehavioral Outcomes

Mechanisms mediating the impact of maternal obesity on offspring hypothalamic development and later function

Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome

Associations between maternal pre-pregnancy BMI and infant striatal mean diffusivity

Fetal malnutrition and long-term outcomes

Maternal obesity: sex-specific in utero changes in fetal brain autophagy and mTOR

Maternal obesity damages the median eminence blood-brain barrier structure and function in the progeny: the beneficial impact of cross-fostering by lean mothers

Maternal high BMI: Sex-dimorphic alterations in maternal and offspring stress indices

Maternal high fat diets: impacts on offspring obesity and epigenetic hypothalamic programming

Origins of obesity in the womb: Fetal adiposity and its determinants

Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model

Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk

Maternal Western diet programs cardiometabolic dysfunction and hypothalamic inflammation via epigenetic mechanisms predominantly in the male offspring

Obesogenic Diet in Mice Leads to Inflammation and Oxidative Stress in the Mother in Association with Sex-Specific Changes in Fetal Development, Inflammatory Markers and Placental Transcriptome

Long term links between maternal diet during pregnancy and offspring health

From Womb to Well-being: The Intricate Link between Psychoneuroendocrinology, Metabolism, and Fetal Programming for Optimal Neurodevelopment and Health

Maternal Diet-induced Obesity Programs Cardiovascular Dysfunction in Adult Male Mouse Offspring Independent of Current Body Weight

Long-Term Effects of Maternal Fat Consumption on the Brain Transcriptome of Obesogenic Diet-Fed Young Adult Mice Offspring

Developmental programming of health and disease